Valvular & structural heart disease
Transjugular Approach for Evoque Transcatheter Tricuspid Valve Replacement in Patients With Challenging Anatomy
Authors' conclusion
In the largest single-center cohort of patients reported to date, transjugular Evoque TTVR demonstrated favorable intraprocedural, periprocedural, and short-term clinical outcomes, and was found to be a feasible alternative for patients with anatomy unsuitable for transfemoral Evoque TTVR.
Study context
- Population
- Patients with challenging anatomy unsuitable for transfemoral Evoque transcatheter tricuspid valve replacement (TTVR), US, February 2024–January 2025
- Participants
- 11 patients
- Outcome
- Feasibility: intraprocedural success (TVARC definitions)
Methodological detailshigh-volume centre
- High-volume centre
Main finding
As reported in the abstract
Intraprocedural success
Transjugular Evoque TTVR
11
events
Observational data: associations, not effects.
Further findings
Clinical success · 30 days
- Clinical success rate
- 100%
Tricuspid regurgitation · 30 days
- None-to-trivial
- 8 patients
- Mild
- 2 patients
- Moderate
- 1 patient
Stroke, mortality, rehospitalization · 30 days
- No stroke, mortality or rehospitalization
NYHA functional class
- Improvement in NYHA class
- 9 out of 11 patients
Safety
Procedural complications
- No major procedural complications except pacemaker implantation
- 1
Stroke, mortality, rehospitalization · 30 days
- No stroke, mortality or rehospitalization
Original publication
Transjugular Approach for Evoque Transcatheter Tricuspid Valve Replacement in Patients With Challenging Anatomy. Circ Cardiovasc Interv. Published 19 August 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →